Co-Founder, Chairman, CEO

Chief Commercial Officer (CCO)

Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion

Celcuity Inc. (CELC)’s FDA NDA for Gedatolisib Accepted Under RTOR, Accelerating Review

Certain Common Stock of Celcuity Inc. are subject to a Lock-Up Agreement Ending on 29-SEP-2025.

Certain Pre-Funded Warrants of Celcuity Inc. are subject to a Lock-Up Agreement Ending on 29-SEP-2025.

Executive Assistant

Celcuity is a clinical-stage biotechnology company focused on developing targeted therapies for cancer treatment. They are seeking an Executive Assistant to provide professional and strategic support to the Chief Commercial Officer and senior leadership team, managing calendars, organizing meetings, and handling sensitive information.

Sign up with Google

Sign in with Google